The 2012 London Regenerative Medicine Event will take place February 16, 2012 at the Penridge Suite in London, England.
Continued improvement in health depends upon the development of affordable and effective medicines and new therapeutic treatments. The last 20 years has seen the growth of a global healthcare industry based on human proteins produced in transformed mammalian cell lines. There is now an opportunity to replicate this growth in new industries using human stem cells in pharmaceutical and regenerative medicine applications.
This meeting will focus on exploring the biological and engineering challenges that lie ahead before cell based therapies can become an everyday reality. The event has CPD accreditation and will have a discussion panel session.
For more information, please visit www.regonline.co.uk/regen2012.